ClassID:

114091

C12Y111/01009 - CPC Classification

Classification description:

Oxidoreductases acting on a peroxide as acceptor (1.11); Peroxidases (1.11.1) Glutathione peroxidase (1.11.1.9)

Recent Application in this class:
#1
20260027190
2026-01-29

OVARIAN TUMOR DEUBIQUITINASE OXIDATION AND USES THEREOF

#2
20260007614
2026-01-08

THROMBOLYTIC AND NEURO/VASCULOPROTECTIVE NANOCONJUGATES

#3
20250066794
2025-02-27

Application of PRDX5 and GPX4 Genes in Preparation of Drugs for Castration-resistant Prostate Cancer

#4
20250001009
2025-01-02

THERAPY FOR PROGRAMMED CELL DEATH IN A SUBJECT TRANSPLANTED WITH A DONOR LIVER CARRYING THE PNPLA3 RS738409:G VARIANT

#5
20220211634
2022-07-07

THROMBOLYTIC AND NEURO/VASCULOPROTECTIVE NANOCONJUGATES

#6
20210032665
2021-02-04

Recombinant yeast strain for producing nervonic acids and application thereof

#7
20170247762
2017-08-31

COMPOSITIONS, METHODS AND USE OF SYNTHETIC LETHAL SCREENING

#8
20160369285
2016-12-22

TERMITE SUPEROXIDE DISMUTASES AND GLUTATHIONE PEROXIDASES FOR BIOMASS CONVERSION

#9
20160068825
2016-03-10

Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect- Cell-Permeable Glutathione Peroxidase7 (CP-GPX7) in Gastrointestinal Track (GIT), Polynucleotides Encoding the Same, and Anti-Cancer Compositions Comprising the Same

#10
20150322449
2015-11-12

Plants Having Enhanced Yield-Related Traits And Methods For Making The Same

#11
20150297564
2015-10-22

METHOD OF ENHANCING GLUCOSE-STIMULATED INSULIN SECRETION AND OF TREATING TYPE 2 DIABETES OR HYPOGLYCEMIA

#12
20150202187
2015-07-23

COMPOSITIONS AND METHODS FOR TREATMENT OF VITILIGO

#13
20110301186
2011-12-08

USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE

#14
20090137617
2009-05-28

USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE

#15
20080175895
2008-07-24

SYSTEM, DEVICES, AND METHODS FOR IONTOPHORETIC DELIVERY OF COMPOSITIONS INCLUDING ANTIOXIDANTS ENCAPSULATED IN LIPOSOMES

#16
20080044399
2008-02-21

Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype

#17
20070014764
2007-01-18

Reduction in myocardial infarction size

#18
20060134088
2006-06-22

Enzymatic treatment of retinitis pigmentosis

#19
20050043258
2005-02-24

Methods of treating xerostomia and xerophthalmia

#20
18918210
2025-08-05

Selenium-containing nano HOF, antioxidant nanozyme, preparation method and application thereof